Alfonso Tramontano graduated in Medical Biotechnology at the Federico II University of Naples in 2015. He obtained his PhD in Scienze Biochimiche e Biotecnologiche at University of Campania in 2020, with a project focused on transcription induction and repression of genes involved in epithelial-mesenchymal transition. Currently, he is a post-Doctoral fellow working on the epigenetic mechanisms involved in vascular diseases.